Skip to Main Content

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) PBMTC SUP1701

Conditions

Other Hematopoietic | Pediatrics

Phase I-II

What is the purpose of this trial?

The purpose of this study is to evaluate whether virus-specific T cell lines (VSTs) are safe and can effectively control three viruses (EBV, CMV, and adenovirus) in patients who have had a stem cell transplant and also in patients that have a primary immunodeficiency disorder with no prior stem cell transplant.

  • Trial with
    Pediatric Blood and Marrow Transplant Consortium
  • Start Date
    08/22/2019
  • End Date
    02/27/2022

For more information about this study, contact:

Carolyn Demsky

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/02/2019
  • Study HIC
    #2000023146